Viveve Medical Inc. (VIVMF) 0.3200 $VIVMF
Viveve Announces Distribution Partnership With Dalton Medical, B.V.
Marketwired - Thu Apr 09, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced a new distribution partnership with Dalton Medical, B.V. ("Dalton Medical"

, a distributor of medical devices based in Oosterhout, Netherlands. The agreement, which covers the Netherlands, Belgium and Luxembourg, combines Dalton Medical's strong presence in the medical device market throughout the region with Viveve's innovative product for treating vaginal laxity. The Viveve® Treatment is now available throughout the United Kingdom, Ireland, Spain, Netherlands, Belgium and Luxembourg.
Viveve Completes Enrollment in the VIVEVE I Clinical Trial
Marketwired - Tue Apr 07, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced the completion of patient enrollment in the VIVEVE I clinical study. The VIveve Treatment of the Vaginal Introitus to EValuate Efficacy study is the first randomized, blinded and sham-controlled trial designed to demonstrate the efficacy of the Viveve® Treatment versus a sham control procedure for the treatment of vaginal introital laxity.
Viveve Announces Distribution Partnership With Global DIA Solutions S.L. of Spain
Marketwired - Wed Apr 01, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced a new distribution partnership with Global DIA Solutions S.L. ("GDS"

, a distributor of medical devices based in Barcelona, Spain with offices in Madrid and Valencia. This partnership combines GDS's expertise in building new medical device markets throughout Spain with Viveve's innovative product for treating vaginal laxity. The Viveve® Treatment is now available throughout the United Kingdom, Ireland, and Spain.
Viveve Appoints James Atkinson Chief Business Officer/President
Marketwired - Mon Feb 09, 3:30PM CST
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that James Atkinson has joined the company as Chief Business Officer and President. In this newly created position, Mr. Atkinson will provide strategic leadership in building the company's global distribution network, positioning Viveve for strong market expansion worldwide. In addition, he will serve as a member of Viveve's executive leadership team where he will contribute to the formulation and execution of the company's strategic vision.
STJ: 68.17 (+0.23)
Viveve Initiates the VIVEVE I Clinical Trial
Marketwired - Tue Dec 16, 7:28AM CST
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that the first patient was successfully treated at the Allan Centre, in Calgary Canada, by Dr. Bruce Allan, a leading Canadian gynecologist. The VIVEVE I clinical study -- VIveve Treatment of the Vaginal Introitus to EValuate Efficacy is a randomized, blinded and sham-controlled trial designed to demonstrate the efficacy of the Viveve® Treatment versus a sham control procedure for the treatment of vaginal introital laxity.
Viveve Presentation Now Available for On-Demand Viewing
PR Newswire - Mon Dec 08, 7:29AM CST
Viveve Medical, Inc. (OTC QB: VIVMF) ("Viveve"

, the parent company to Viveve, Inc., a company focused on women's health, today announced that the December 4th presentation, is now available for on-demand viewing at VirtualInvestorConferences.com.
Viveve Announces Presentation at World Meeting in Paris
Marketwired - Wed Dec 03, 9:24AM CST
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that Dr. Michael Krychman, a medical advisor to the company, a world renowned specialist in sexual health and the Executive Director of The Southern California Center for Sexual Health and Survivorship, will present the Viveve® System as a non-invasive treatment for vaginal introital laxity to improve sexual function in adult females during the 20th World Congress in Obstetrics, Gynecology & Infertility, being held December 4th through the 7th in Paris.
Eight Companies Webcast Live to Investors, December 4th at VirtualInvestorConferences.com
PR Newswire - Tue Dec 02, 7:29AM CST
CEOs and top executives to take questions in real-time during formal roadshow presentations as well as meet and "chat" in virtual trade booths
SMLR: 3.80 (+0.17), ONVO: 4.16 (-0.05), CYTX: 1.24 (-0.02), IAG: 2.02 (+0.06)
Viveve to Webcast Live at VirtualInvestorConferences.com
PR Newswire - Mon Nov 24, 7:28AM CST
Company invites individual and institutional investors, as well as advisors to attend this interactive, real-time virtual investor conference
Viveve Announces the Launch of Its New Website
Marketwired - Wed Nov 19, 4:27PM CST
Viveve Medical, Inc. ("Viveve"

(PINKSHEETS: VIVMF), the parent company to Viveve, Inc., a company focused on women's health, today announced that it unveiled its new website www.viveve.com. The site now offers a clean, modern design, easy-to-navigate functionality, and a content-rich experience.
The Viveve System Offers Better Alternative To Treat Vaginal Laxity
Brian Marckx, CFA - at Seeking Alpha - Wed Nov 19, 3:28PM CST
VRX: 207.50 (+1.78)
Viveve to Present at the Canaccord Genuity - 2014 Medical Technology & Diagnostics Forum
Marketwired - Tue Nov 18, 11:44PM CST
Viveve Medical, Inc. ("Viveve"

(PINKSHEETS: VIVMF), a company focused on women's health, today announced that Patricia Scheller, Chief Executive Officer, will present at the Canaccord Genuity, 2014 Medical Technology & Diagnostics Forum on Thursday, November 20th at 8:20am EST at the Westin Grand Central in New York, NY.
Viveve Reports Third Quarter 2014 Financial Results
Marketwired - Fri Nov 14, 8:25AM CST
Viveve Medical, Inc. ("Viveve"

(PINKSHEETS: VIVMF), the parent company to Viveve, Inc., a company focused on women's health, today reported financial results for the period ended September 30, 2014. These results are the first financial results reported for Viveve following the merger of Viveve, Inc. with PLC Systems, Inc.